By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login

Bicara Therapeutics Inc. Common Stock (BCAX)

NASDAQ Currency in USD
$11.98
+$0.05
+0.42%
Last Update: 11 Sept 2025, 20:00
$653.66M
Market Cap
-6.77
P/E Ratio (TTM)
Forward Dividend Yield
$7.80 - $28.09
52 Week Range

BCAX Stock Price Chart

Explore Bicara Therapeutics Inc. Common Stock interactive price chart. Choose custom timeframes to analyze BCAX price movements and trends.

BCAX Company Profile

Discover essential business fundamentals and corporate details for Bicara Therapeutics Inc. Common Stock (BCAX) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

Employees

55.00

CEO

Claire Mazumdar Clemon

Description

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts. Bicara Therapeutics Inc. is a subsidiary of Biocon Limited.

BCAX Financial Timeline

Browse a chronological timeline of Bicara Therapeutics Inc. Common Stock corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 11 Nov 2025

EPS estimate is -$0.55.

Earnings released on 12 Aug 2025

EPS came in at -$0.50 surpassing the estimated -$0.54 by +7.41%.

Earnings released on 13 May 2025

EPS came in at -$0.68 falling short of the estimated -$0.40 by -70.00%.

Earnings released on 27 Mar 2025

EPS came in at -$0.39 falling short of the estimated -$0.31 by -25.81%.

Earnings released on 12 Nov 2024

EPS came in at -$1.60 falling short of the estimated -$0.46 by -247.83%.

Earnings released on 13 Sept 2024

EPS came in at -$0.27 .

Earnings released on 30 Jun 2024

EPS came in at -$0.27 .

Earnings released on 31 Dec 2023

EPS came in at -$0.23 .

Earnings released on 30 Sept 2023

EPS came in at -$0.42 .

Earnings released on 30 Jun 2023

EPS came in at -$0.15 .

Earnings released on 31 Mar 2023

EPS came in at -$0.15 .

BCAX Stock Performance

Access detailed BCAX performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run